Hamid, Amira H.
HRN: 23-95-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/26/2023
11/01/2023
IV
85mg
Q8
AGE
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Non-compliant To Guidelines